MoCRA enforcement now makes FDA facility registration, product listing, and contamination control mandatory for tattoo inks, forcing studios to demand full documentation from suppliers. Cross-border operators must reconcile US MoCRA requirements with EU REACH Annex XVII substance bans and NEHA-based state practice codes.
What the full article covers
Tattoo inks are now fully treated as cosmetics under MoCRA, with mandatory FDA facility registration and product listing.
The FDA’s October 2024 final guidance on microbial contamination is now driving real enforcement, inspections, and recalls.
Studios must demand supplier FDA registration numbers, product listing confirmation, and full ingredient lists with CAS numbers for every ink.
Non‑registered or non‑listed inks are now regulatory liabilities; studios risk enforcement and civil litigation if they keep using them.
Cross‑border operators must reconcile MoCRA requirements with EU REACH Annex XVII tattoo ink restrictions and state adoption of the NEHA Body Art Model Code.
Read the full engineering article on Poli International →
Full data, references, and the complete technical breakdown, free, no signup.
First published on poliinternational.com. This is a summary of the original engineering article.
Top comments (0)